This study discovered a new and reliable method to measure a peptide called proline-glycine-proline (PGP) in human plasma. This is important because PGP levels could be a potential biomarker for chronic lung disease and cancer, and this method could lead to disease detection earlier, and potentially be a therapeutic target. Senior Author J. Michael Wells MD was funded by an American Lung Association ACRC Pilot award.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.